Cocaine Use and Risk of Ischemic Stroke in Young Adults
Stroke 47:918-922, Cheng, Y.C.,et al, 2016
Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 47:1127-1130, Purrucker, J.C.,et al, 2016
Stroke in Commercial Flights
Stroke 47:1117-1119, Alvarez-Velasco, R.,et al, 2016
Stroke as the Initial Manifestation of the Human Immunodeficiency Virus
Stroke 47:e60-e62, Manwani, B.,et al, 2016
Restless Legs Syndrome Associated with Major Diseases
Neurol 86:1336-1343, Trenkwalder, C.,et al, 2016
Embolic Stroke, Atrial Fibrillation, and Microbleeds
Stroke 47:904-907, Diener, H-C.,et al, 2016
Metronidazole-Associated Encephalopathy
NEJM 374:1465, Baden, L.R., 2016
Zika Virus
NEJM 374:1552-1563, Petersen, L.R.,et al, 2016
One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
NEJM 374:1533-1542,1577, Amarenco, P.,et al, 2016
Rituximab Treatment for Autoimmune Limbic Encephalitis in an Institutional Cohort
Neurol 86:1683-1691,1655, Lee, W.J.,et al, 2016
Prognosis of Asymptomatic Carotid Artery Occlusion
Stroke 47:1253-1257, Hackam, D.G.,et al, 2016
Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 387:1921-1927,1882, Villiger, P.M.,et al, 2016
A 38-Year-Old Man with Respiratory Failure and Progressive Leg Weakness
Neurol 86:e190-e194, McIntosh, P. & Karam, C., 2016
An Unusual Case of Blurry Vision in a Young Woman After Ovarian Induction
Neurol 87:e49-e53, Parikh, N.S.,et al, 2016
Primary Prevention of Stroke
JAMA 316:658-659, Steiger, N. & Cifu, A.S., 2016
Stability of International Normalized Ratios in Patients Taking Long-Term Warfarin Therapy
JAMA 316:661-662, Pokorney, S.D.,et al, 2016
Chikungunya Virus-Associated Encephalitis
Neurol 86:94-102, Gerardin, P.,et al, 2016
Retinal Artery Occlusion and the Risk of Stroke Development
Stroke 47:376-382, Hyungtaek, T.,et al, 2016
Tranexamic Acid-Associated Seizures: Causes and Treatment
Ann Neurol 79:18-26, Lecker, I.,et al, 2016
Bright Tongue Sign in Pompe Disease
Neurol 86:401, Karam, C., 2016
An 11-year-old Boy with Language Disorder and Epilepsy
Neurol 86:e48-e53, Dong, L. & Zhou, X., 2016
Natalizumab-Related PML 2 Weeks after Negative Anti-JCV Antibody Assay
Neurol 86:484-486, Gagne, M.S.,et al, 2016
Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants
JAMA Neurol 73:169-177,155, Purrucker, J.C.,et al, 2016
Zika Virus Associated with Microcephaly
NEJM 374: DOI:10.1056/NEJMoa1600651, Mlakar, J.,et al, 2016
Carotid Near-Occlusion: A Comprehensive Review, Part 2- Prognosis and Treatment, Pathophysiology, Confusions, and Areas for Improvement
AJNR 37:200-204, Johansson, E. & Fox, A.J., 2016
MRI Findings of Biotin-Responsive Basal Ganglia Disease Before and After Treatment
Neurol 86:e71-e72, Saeedan, M.B. & Dogar, M.A., 2016
Trousseaus Syndrome: Cancer-Associated Thrombosis
Jpn J Clin Oncol 46:204-207, Ikushima, S.,et al, 2016
Cysticercal Encephalitis: An Unusual Differential in the List of Encephalitis
IJCMR 3:2264-2266, Ajeet, S.,et al, 2016
Myasthenia Gravis after Botulinum Toxin Type A Injection
Turk J Neurol 22:143-144, Tekce, H.D.,et al, 2016
Idiopathic Thoracic Spontaneous Spinal Epidural Hematoma
Case Reports Surg doi:10.1155/2016/5430708, Aycan, A.,et al, 2016
A Woman with Intellectual Disability, Amenorrhoea, Seizures, and Balance Problems
JAMA Neurol 73:1494-1495, Hughes, A.J.C.,et al, 2016
Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Eur J Cancer 54:139-148, Michot, JM,.,et al, 2016
Acute Demyelinating Polyneuropathy Caused by Nivolumab in a Man with Metastatic Non-Small Cell Lung Cancer
J Gerontol Geriatr Res 5:3, Sabeeh-Ur-Rehman, B. & Bhaumik, S., 2016
Treatment of Brain Metastases
J Clin Oncol 33:3475-3484, Lin, X. & DeAngelis, L.M., 2015
Risk of Recurrent Neurologic Stroke or Transient Ischemic Attack in Patients with Cryptogenic Stroke and Intrapulmonary Shunt
Echocardiography 33:276-280, Sinha, R.S.,et al, 2015
Factors Associated with Mortality in Extrapulmonary Tuberculosis Patients at a Teaching Hospital in Ghana
Ghana Med J 49:233-238, Nassikas, N.,et al, 2015
Acute Flaccid Myelitis of Unknown Etiology in California 2012-2015
JAMA 314:2663-2671, Van Haren, K.,et al, 2015
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
NEJM 373:2413-2424,2471, Siegal, D.M.,et al, 2015
Lithium Therapy in Kleine-Levin Syndrome
Neurol 85:1655-1662, Leu-Semenescu, S.,et al, 2015
Bells Palsy: Aetiology, Clinical Features and Multidisciplinary Care
JNNP 86:1356-1361, Eviston, T.J.,et al, 2015
A Young Woman with Blurred Vision and Distal Paresthesias
JAMA Neurol 72:1519-1523, Kung, N.H.,et al, 2015
Seizures from Solving Sudoku Puzzles
JAMA Neurol 72:1524-1526, Feddersen, B.,et al, 2015
Left Atrial Appendage Function and Stroke Risk
Stroke 46:3554-3559, Yaghi, S.,et al, 2015
Endovascular Treatment for Acute Ischemic Stroke in the Setting of Anticoagulation
Stroke 46:3536-3539, Rebello, L.C.,et al, 2015
Nontraditional Risk Factors for Ischemic Stroke
Stroke 46:3572-3578, Bang, O.Y.,et al, 2015
Molybdenum Cofactor Deficiency
Neurol 85:e175-e178, Nagappa, M.,et al, 2015
FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant Pradaxa
JAMA 314:2227, , 2015
A 48-year-old Man with Walking Difficulty
Neurol 85:e165-e169, Kalladka, D.,et al, 2015
Clinical Characteristics and Prognosis of Mah-Jong-Induced Epilepsy: A Cohort Review of 56 Patients
Epilepsy & Behavior 53:117-119, An, D.,et al, 2015